Results 31 to 40 of about 76,161 (283)

Transcatheter Exclusion of a Large Pseudoaneurysm of a Systemic Right Ventricular Outflow Tract

JACC: Case Reports, 2021
We describe a rare patient with a large pseudoaneurysm of the right ventricular outflow tract that had developed after placement of a right ventricle–pulmonary artery conduit. A 7-mm Amplatzer Septal Occluder device was used to exclude the pseudoaneurysm,
James S. Krulisky, MD, Timothy Pettitt, MD, Ernest Siwik, MD, Kiran K. Mallula, MD   +3 more
doaj   +1 more source

Transcatheter Aortic Valve Implantation in Dialysis Patients [PDF]

, 2012
Background/Aims: Transcatheter aortic valve implantation (TAVI) has emerged as a new therapeutic option for high-risk patients. However, dialysis patients were excluded from all previous studies.
Wessely, Matthias, Schoenermarck, Ulf, Rau, Simon, Fischereder, Michael, Steinbeck, Gerhard, Kupatt, Christian, Lange, Philipp   +6 more
core   +1 more source

Successful perioperative management of simultaneous transcatheter aortic valve implantation and hip fracture surgery: a case report [PDF]

, 2023
A 90-year-old woman with severe aortic stenosis experienced hospital readmission for chronic heart failure exacerbations many times and was admitted to our hospital for undergoing transcatheter aortic valve implantation.
Aoki, Yohei, Momohara, Hironori, Nonogaki, Mikio, Aoyama, Tadashi, Yamane, Kochi   +4 more
core   +1 more source

India’s first successful ECMO assisted TAVI: A strategy for ‘high risk’ TAVI patients

IHJ Cardiovascular Case Reports, 2017
Transcatheter Aortic Valve Implantation (TAVI) is a well established treatment for patients with symptomatic aortic stenosis and who are high risk for conventional surgical aortic valve replacement.
A.B. Gopalamurugan, M.S. Meenakshi, R. Mohamed Abubacker   +2 more
doaj   +1 more source

Coronary revascularization after surgical aortic valve replacementCentral MessagePerspective

JTCVS Open, 2020
Objective: It remains unclear how often coronary revascularization is necessary after aortic valve interventions, either by surgical aortic valve replacement (SAVR) or transcatheter aortic valve replacement. However, these data are relevant for treatment
Mevlüt Çelik, BSc, Andras P. Durko, MD, Stuart J. Head, MD, PhD, Edris A.F. Mahtab, MD, PhD, Nicolas M. van Mieghem, MD, PhD, Paul A. Cummins, MSc, Arie P. Kappetein, MD, PhD, Ad.J.J.C. Bogers, MD, PhD   +7 more
doaj   +1 more source

Cost-utility of transcatheter aortic valve implantation for inoperable patients with severe aortic stenosis treated by medical management: a UK cost-utility analysis based on patient-level data from the ADVANCE study. [PDF]

, 2014
OBJECTIVE: To use patient-level data from the ADVANCE study to evaluate the cost-effectiveness of transcatheter aortic valve implantation (TAVI) compared to medical management (MM) in patients with severe aortic stenosis from the perspective of the UK ...
Busca, R, Axel Linke, Amie Padhiar, Peter Wenaweser, Neil Moat, Piazza, N, Stuart Mealing, Johan Bosmans, Mealing, S, Stephen Brecker, Mark Sculpher, Ulrich J Gerckens, Nicolo Piazza, Rachele Busca, Padhiar, A, Sabine Bleiziffer, Tamburino, C, Sculpher, M, Bosmans, J, Gerckens, UJ, Bleiziffer, S, Linke, A, James Eaton, Eaton, J, Wenaweser, P, Moat, N, Corrado Tamburino, Brecker, S   +27 more
core   +1 more source

Multimodality Treatment with Conventional Transcatheter Arterial Chemoembolization and Radiofrequency Ablation for Unresectable Hepatocellular Carcinoma [PDF]

, 2011
Background/Aims: To evaluate the efficacy of multimodality treatment consisting of conventional transcatheter arterial chemoembolization (TACE) and radiofrequency ablation (RFA) in patients with non-resectable and non-ablatable hepatocellular carcinoma ...
Rentsch, M., P. Paprottka, F.T. Kolligs, M. Rentsch, Paprottka, P., T.F. Jakobs, Kolligs, F. T., Reiser, Maximilian F., Jakobs, T. F., Ashoori, N., F. Bamberg, Bamberg, F., Trumm, C., N. Ashoori, C. Trumm, M.F. Reiser   +15 more
core   +1 more source

c‐Rel–dependent Chk2 signaling regulates the DNA damage response limiting hepatocarcinogenesis

Hepatology, EarlyView., 2022
In response to genotoxic injury, c‐Rel upregulates ATM‐Chk2‐p53 pathway DNA damage proteins to limiting hepatocarcinogenesis. Abstract Background and Aims Hepatocellular carcinoma (HCC) is a leading cause of cancer‐related death. The NF‐κB transcription factor family subunit c‐Rel is typically protumorigenic; however, it has recently been reported as a
Jack Leslie, Jill E. Hunter, Amy Collins, Amelia Rushton, Lauren G. Russell, Erik Ramon‐Gil, Maja Laszczewska, Misti McCain, Marco Y. W. Zaki, Amber Knox, Yixin Seow, Laura Sabater, Daniel Geh, Neil D. Perkins, Helen L. Reeves, Dina Tiniakos, Derek A. Mann, Fiona Oakley   +17 more
wiley   +1 more source

Contrast-enhanced CMR in patients after percutaneous closure of the left atrial appendage: A pilot study [PDF]

, 2011
Background To evaluate the feasibility and value of first-pass contrast-enhanced dynamic and post-contrast 3D CMR in patients after transcatheter occlusion of left atrial appendage (LAA) to identify incorrect placement and persistent leaks.
Steffen E Petersen, Petersen, SE, Mohrs, OK, Nina Wunderlich, Anselm Pottmeyer, Petersen Steffen E, Wunderlich, N, Pottmeyer, A, Hans-Ulrich Kauczor, Mohrs Oliver K, Pottmeyer Anselm, Kauczor, HU, Wunderlich Nina, Kauczor Hans-Ulrich, Oliver K Mohrs   +14 more
core   +1 more source

Long-term Transcatheter Aortic Valve Durability [PDF]

, 2019
Transcatheter aortic valve implantation (TAVI) has become the standard of care for high-risk and inoperable surgical patients and a valid alternative to surgery for low- and intermediate-risk patients with severe, symptomatic aortic stenosis.
Enrico Criscione, Denise Todaro, Marco Barbanti, Corrado Tamburino, Giuliano Costa   +4 more
core   +1 more source